COURTNEY TAYLOR: Open Payments
NPI 1215358395 · LIVINGSTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$608 in 36 payments from 11 companies in 2025. Trend: 2023 $544 · 2024 $655 · 2025 $608
Food & beverage: $608
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $171 |
| Lilly USA, LLC | 6 | $102 |
| Axsome Therapeutics, Inc. | 4 | $94 |
| Corium, LLC | 4 | $56 |
| Novo Nordisk Inc | 3 | $54 |
| Vanda Pharmaceuticals Inc. | 1 | $36 |
| PFIZER INC. | 1 | $22 |
| Lundbeck LLC | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
Products named: VRAYLAR, MOUNJARO, Auvelity, Azstarys, Ozempic, QULIPTA, FANAPT, ELIQUIS.
Industry payments across LA — which companies pay providers there.
